| [1] |
CASTAMAN G, PEYVANDI F, DE CRISTOFARO R, et al. Mild and moderate hemophilia A: neglected conditions, still with unmet needs[J]. J Clin Med, 2023, 12(4): 1368. DOI: 10.3390/jcm12041368.
|
| [2] |
SHIMA M, AMANO K, OGAWA Y, et al. A prospective, multicenter, open-label phase Ⅲ study of emicizumab prophylaxis in patients with acquired hemophilia A[J]. J Thromb Haemost, 2023, 21(3): 534-545. doi: 10.1016/j.jtha.2022.10.004
|
| [3] |
LING X T, PAN L Q, LI L L, et al. Detection of hemophilia A genetic variants using third-generation long-read sequencing[J]. Clin Chim Acta, 2024, 562: 119884. DOI: 10.1016/j.cca.2024.119884.
|
| [4] |
CHEN Y L, CHENG S J, THORNHILL T, et al. Health care costs and resource use of managing hemophilia A: a targeted literature review[J]. J Manag Care Spec Pharm, 2023, 29(6): 647-658.
|
| [5] |
BRINZA M, GRIGORE A, DRAGOMIR M, et al. Large Intron Inversions in Romanian patients with hemophilia A: first report[J]. Medicina (Kaunas), 2023, 59(10): 1821. DOI: 10.3390/medicina59101821.
|
| [6] |
马静瑶, 陈振萍, 李刚, 等. 基因突变致新生儿期发病的血管性血友病2B型一例[J]. 中华儿科杂志, 2021, 59(3): 233-235.MA J Y, CHEN Z P, LI G, et al. von Willebrand disease type 2B caused by gene mutation in a newborn[J]. Chinese Journal of Pediatrics, 2021, 59(3): 233-235.
|
| [7] |
SAMII A, NOROUZI M, AHMADI A, et al. Gastrointestinal bleeding in congenital bleeding disorders[J]. Semin Thromb Hemost, 2022, 48(5): 529-541. doi: 10.1055/s-0041-1741571
|
| [8] |
MIN J, CHO M H, BAE S P, et al. A premature baby with severe oligohydramnios and hypotension: a case report of renal tubular dysgenesis[J]. J Korean Med Sci, 2020, 35(32): e283. DOI: 10.3346/jkms.2020.35.e283.
|
| [9] |
HAN J H, DUPERVIL B, MAHAJERIN A, et al. Clinical and treatment characteristics of infants and toddlers less than 2 years of age with hemophilia[J]. Blood Adv, 2024, 8(11): 2707-2717. doi: 10.1182/bloodadvances.2023012486
|
| [10] |
JOURDY Y, BARDEL C, FRETIGNY M, et al. Complete characterisation of two new large Xq28 duplications involving F8 using whole genome sequencing in patients without haemophilia A[J]. Haemophilia, 2022, 28(1): 117-124. doi: 10.1111/hae.14402
|
| [11] |
ASHFAQ J, AHMED R, TARIQ F, et al. Frequency of intron 22 inversion in severe hemophilia A patients[J]. Cureus, 2022, 14(8): e28247. DOI: 10.7759/cureus.28247.
|
| [12] |
DOWNES K, MEGY K, DUARTE D, et al. Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders[J]. Blood, 2019, 134(23): 2082-2091. doi: 10.1182/blood.2018891192
|
| [13] |
HALSTEAD-NUSSLOCH G, SIGNORINI SG, GIULIO M, et al. The genome of the rayed Mediterranean limpet Patella caerulea (Linnaeus, 1758)[J]. Genome Biol Evol, 2024, 16(4): evae070. DOI: 10.1093/gbe/evae070.
|
| [14] |
AHMED A E, PRATT K P. Race, ethnicity, F8 variants, and inhibitor risk: analysis of the "My Life Our Future" hemophilia A database[J]. J Thromb Haemost, 2023, 21(4): 800-813. doi: 10.1016/j.jtha.2022.12.017
|
| [15] |
梅道启, 王媛, 梅世月, 等. MECP2基因新生无义突变导致Rett综合征1例的临床特点及分子遗传学分析[J]. 中华全科医学, 2020, 18(2): 332-334.MEI D Q, WANG Y, MEI S Y, et al. Clinical features and molecular genetic analysis of a case of Rett syndrome caused by de novo nonsense mutation in MECP2 gene[J]. Chinese Journal of General Practice, 2020, 18(2): 332-334.
|
| [16] |
CHEAR C T, ISMAIL I H, CHAN K C, et al. Clinical features and mutational analysis of X-linked agammaglobulinemia patients in Malaysia[J]. Front Immunol, 2023, 14: 1252765. DOI: 10.3389/fimmu.2023.1252765.
|